Stockscreener 앱 받기
42.25
1.83%
0.76
시간 외 거래:
42.85
0.60
+1.42%
전일 마감가:
$41.49
열려 있는:
$44.18
하루 거래량:
8.63M
Relative Volume:
2.01
시가총액:
$4.71B
수익:
-
순이익/손실:
$-99.15M
주가수익비율:
-45.43
EPS:
-0.93
순현금흐름:
$-74.25M
1주 성능:
-10.16%
1개월 성능:
-18.01%
6개월 성능:
-16.22%
1년 성능:
+139.78%
1일 변동 폭
$41.98
$45.00
1주일 범위
$37.80
$48.55
52주 변동 폭
$17.23
$99.41
Viking Therapeutics Inc Stock (VKTX) Company Profile
명칭
Viking Therapeutics Inc
전화
858-704-4660
주소
9920 PACIFIC HEIGHTS BLVD, SUITE 350, SAN DIEGO, CA
VKTX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VKTX
Viking Therapeutics Inc
|
42.25 | 4.71B | 0 | -99.15M | -74.25M | -0.93 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.27 | 102.31B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
701.85 | 77.13B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
623.82 | 37.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
245.44 | 31.66B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
113.08 | 27.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Viking Therapeutics Inc Stock (VKTX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-02 | 개시 | Piper Sandler | Overweight |
| 2024-11-22 | 개시 | B. Riley Securities | Buy |
| 2024-11-04 | 재확인 | H.C. Wainwright | Buy |
| 2024-09-11 | 개시 | JP Morgan | Overweight |
| 2024-06-27 | 개시 | Morgan Stanley | Overweight |
| 2024-05-16 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2024-03-26 | 재확인 | Oppenheimer | Outperform |
| 2024-03-07 | 개시 | Jefferies | Buy |
| 2024-02-28 | 재확인 | Oppenheimer | Outperform |
| 2023-05-31 | 재개 | ROTH MKM | Buy |
| 2023-03-28 | 재확인 | Maxim Group | Buy |
| 2023-03-17 | 개시 | Stifel | Buy |
| 2021-07-29 | 재개 | BTIG Research | Buy |
| 2021-05-25 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2020-06-05 | 개시 | BMO Capital Markets | Outperform |
| 2020-05-05 | 개시 | Chardan Capital Markets | Buy |
| 2020-05-01 | 개시 | BTIG Research | Buy |
| 2019-07-16 | 개시 | Oppenheimer | Outperform |
| 2019-06-25 | 개시 | Stifel | Buy |
| 2019-03-29 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2019-03-14 | 재확인 | Maxim Group | Buy |
| 2019-02-22 | 개시 | SVB Leerink | Mkt Perform |
| 2018-12-12 | 개시 | B. Riley FBR | Buy |
| 2018-11-19 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2018-09-18 | 재확인 | H.C. Wainwright | Buy |
| 2018-09-18 | 재확인 | Maxim Group | Buy |
| 2018-09-18 | 재확인 | Raymond James | Outperform |
| 2018-07-20 | 개시 | SunTrust | Buy |
| 2018-06-28 | 개시 | Raymond James | Outperform |
| 2018-06-01 | 재확인 | Laidlaw | Buy |
| 2018-05-31 | 재확인 | Maxim Group | Buy |
| 2018-03-26 | 재개 | H.C. Wainwright | Buy |
| 2017-11-28 | 재확인 | Maxim Group | Buy |
| 2017-11-21 | 개시 | ROTH Capital | Buy |
모두보기
Viking Therapeutics Inc 주식(VKTX)의 최신 뉴스
Down 18% in 1 Day, Is Viking Therapeutics Stock in Trouble Due to Merck? - MSN
Down 18% in 1 Day, Is Viking Therapeutics Stock in Trouble Due to Merck? - The Motley Fool
Why Viking Therapeutics (VKTX) Stock is Down Today - GuruFocus.com
Why Viking Therapeutics Tumbled by More Than 10% This Week - MSN
Viking Therapeutics, Inc. (VKTX) Outpaces Stock Market Gains: What You Should Know - Yahoo Finance
Why Novo Nordisk Stock Got Destroyed Today, but Eli Lilly and Viking Stocks Are Up - sharewise
Viking Therapeutics (NASDAQ:VKTX) Trading 4.8% HigherStill a Buy? - MarketBeat
Looking Into Viking Therapeutics's Recent Short Interest - Benzinga
Viking Therapeutics (VKTX) Sees Surge Amid Novo Nordisk Clinical Trial Results - GuruFocus.com
Viking Therapeutics (NASDAQ:VKTX) Shares Gap UpTime to Buy? - MarketBeat
Viking Therapeutics stock surges 12% amid Novo Nordisk trial woes By Investing.com - Investing.com Canada
Here's Why VKTX Stock Plummeted 18% on Wednesday - MSN
Viking Therapeutics (NASDAQ:VKTX) Trading Up 7.2%Time to Buy? - MarketBeat
Viking Therapeutics: Competition Fears Are Exaggerated (NASDAQ:VKTX) - Seeking Alpha
Viking Therapeutics: Holiday Gift (NASDAQ:VKTX) - Seeking Alpha
Companies Like Viking Therapeutics (NASDAQ:VKTX) Can Afford To Invest In Growth - Yahoo Finance
MML Investors Services LLC Increases Stock Holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX) - MarketBeat
Viking Therapeutics, Inc. (NASDAQ:VKTX) Shares Sold by XTX Topco Ltd - MarketBeat
Viking Therapeutics Garners Analyst Support For NASH And Metabolic Programs - AOL
Viking Therapeutics Stock Slides After Merck Strikes GLP-1 Deal With Chinese Biopharma, Retail Unperturbed - MSN
Viking Therapeutics (NASDAQ:VKTX) Trading Down 8.9%Should You Sell? - MarketBeat
Viking Plummets After Merck Inks A $2.01 Billion Obesity Deal — With Someone Else - Investor's Business Daily
Why Viking Therapeutics (VKTX), HEICO Corporation (HEI), and ABM Industries (ABM) Stocks Are Plunging Today? - Insider Monkey
Viking Therapeutics (NASDAQ:VKTX) Shares Gap DownWhat's Next? - MarketBeat
What's Going On With Viking Therapeutics Stock On Wednesday? - Yahoo Finance
Merck-Hansoh deal for oral GLP-1 hurts obesity drug developers - Seeking Alpha
Smart Money Is Betting Big In VKTX Options - Benzinga
HC Wainwright Reiterates Buy Rating for Viking Therapeutics (NASDAQ:VKTX) - MarketBeat
Viking Therapeutics lower after Merck signs pact with Hansoh for GLP-1 drug - TipRanks
(VKTX) Proactive Strategies - Stock Traders Daily
Viking Therapeutics (NASDAQ:VKTX) Trading Up 0.6%Here's What Happened - MarketBeat
Prediction: Acquisitions Will Skyrocket Under The Trump Administration. Here's 1 Pharmaceutical Company I Have My Eyes On. - AOL
Is Viking Therapeutics, Inc. (VKTX) the Best Weight Loss Stock to Buy Now According to Hedge Funds? - Insider Monkey
Viking Therapeutics: Caution Ahead Of Novo's CagriSema Readout (Rating Downgrade) - Seeking Alpha
Viking Therapeutics (NASDAQ:VKTX) Trading Up 2%Still a Buy? - MarketBeat
2 Soaring Stocks That Could Climb 68% to 166% Higher in 2025, According to Wall Street - Yahoo Finance
Viking Therapeutics, Inc. (VKTX) Stock Moves -1.75%: What You Should Know - MSN
Viking Therapeutics (NASDAQ:VKTX) Trading Down 2.4%What's Next? - MarketBeat
Vestcor Inc Purchases Shares of 11,700 Viking Therapeutics, Inc. (NASDAQ:VKTX) - MarketBeat
Viking Therapeutics, Inc. (NASDAQ:VKTX) Receives $106.75 Average Target Price from Analysts - MarketBeat
Stifel Financial Corp Increases Holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX) - MarketBeat
Viking Therapeutics is Now Oversold (VKTX) - Nasdaq
Viking Therapeutics (NASDAQ:VKTX) Stock Price Down 1.8%Should You Sell? - MarketBeat
Viking Therapeutics to Participate at Upcoming Investor Conferences - The Eastern Progress Online
Viking Therapeutics to Participate at Morgan Stanley 22nd Annual Global Healthcare Conference - The Eastern Progress Online
State Street Corp Reduces Stock Holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX) - MarketBeat
Viking Therapeutics (NASDAQ:VKTX) Shares Down 2.7%Time to Sell? - MarketBeat
Viking Therapeutics (NASDAQ:VKTX) Shares Up 1.8%Still a Buy? - MarketBeat
Viking Therapeutics to Participate in Upcoming Investor Conferences and Events - Marketscreener.com
The Zacks Analyst Blog Eli Lilly, Novo Nordisk's Amgen and Viking Therapeutics - Yahoo Finance
2 'Strong Buy' Biotech Stocks With 120% or More Upside Potential - MSN
Viking Therapeutics Inc (VKTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Viking Therapeutics Inc 주식 (VKTX) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| MACARTNEY LAWSON | Director |
Nov 08 '24 |
Sale |
68.67 |
2,000 |
137,333 |
47,965 |
2.88%
2.65%
자본화:
|
볼륨(24시간):